Federal Project Grant Award Summary Tufts University School of Medicine received a $151,040 Project Grant awarded January 1, 2026, through the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award funds research to identify and characterize the unique cell division machinery of Clostridioides difficile, a major nosocomial pathogen. The research will employ forward genetic selection and candidate-based...
Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Tufts University School of Medicine a Project Grant of $182,424 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on October 24, 2025. The grant funds research investigating how spatial distribution and toxin gene expression of Clostridioides difficile (C. difficile) affect disease severity. The research addresses a critical gap in understanding C. difficile infection (CDI), the...
Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Tufts University School of Medicine a Project Grant of $453,750 under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct biomedical research on bacterial pathogenesis and host immune response mechanisms. Awarded on February 2, 2026, with completion targeted for January 31, 2028, the project investigates how the bacterium Shigella flexneri suppresses...
Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Tufts University School of Medicine a $450,630 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) for a two-year project period from August 1, 2025, through July 31, 2027. The award funds spatiotemporal investigation of interactions between pneumolysin, pulmonary epithelium, and polymorphonuclear leucocytes (PMNs/neutrophils) that contribute to...
Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $247,500 to Tufts University School of Medicine on May 18, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to support research analyzing AgrA-mediated transcription regulation in Listeria monocytogenes. The project, with an ultimate completion date of April 30, 2028, will identify the complete set of genes directly regulated by AgrA, a key transcriptional...
Federal Project Grant Award Summary Emory University received a $100,228 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded September 30, 2026, with a completion date of September 29, 2028. The award supports research investigating interactions of a conserved regulatory switch that controls physiology in spore-forming bacteria, specifically Bacilli and Clostridia species. The...
Federal Project Grant Award Summary Tufts University School of Medicine received a $3.18M Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded August 26, 2025, with completion expected July 31, 2029. The award funds investigation of Yop effector protein activities in Microfold (M) cells during murine infection with Yersinia pseudotuberculosis (YPTB). The research utilizes a...
Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded $529,512 to the Regents of the University of Minnesota on February 20, 2026, for a five-year project grant extending through January 31, 2031. This project grant supports fundamental research aimed at defining the intoxication mechanism of Clostridioides difficile transferase (CDT), a toxin produced by the bacterium...
Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Tufts University School of Medicine a Project Grant of $859,278 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on February 19, 2026, with a completion date of January 31, 2031. The award funds research to accelerate the discovery of narrow-spectrum antibiotics against Borrelia burgdorferi, the causative agent of Lyme disease. Unlike conventional broad-spectrum...
Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Tufts University School of Medicine a $412,377 Project Grant on September 10, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop and optimize in vitro cultivation systems for Enterocytozoon bieneusi (EB), a clinically significant opportunistic microsporidian fungus responsible for persistent diarrhea and wasting in immunocompromised populations,...
Federal Project Grant Award Summary
The National Institute of Allergy and Infectious Diseases (NIAID) awarded Tufts University School of Medicine a $227,640 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) on September 30, 2026, with completion anticipated by March 29, 2029. The award funds research into the molecular mechanisms regulating amidase activity during bacterial spore development in Clostridioides difficile, a significant pathogenic organism. The research employs genetic, biochemical, and structural approaches to elucidate three critical areas: the allosteric activation circuit controlling zinc cofactor binding in the CWLD amidase enzyme, the mechanisms governing CWLD localization during forespore development, and the impact of CWLD on cortex synthesis and coat assembly. Understanding these regulatory pathways has direct implications for understanding spore germination and disease initiation in clostridial pathogens.
The project deliverables include experimental findings and peer-reviewed scientific publications documenting the conformational changes induced by GERS (a regulatory lipoprotein) binding to CWLD, the identification of key regulatory regions controlling zinc binding, and clarification of the localization signals that position CWLD around the developing forespore. These outputs advance fundamental knowledge of bacterial spore biology and may inform the development of novel antimicrobial strategies targeting spore-forming pathogens of public health importance.